Literature DB >> 25413415

Implementation of contemporary radiation therapy planning concepts for pediatric Hodgkin lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.

David C Hodgson1, Karin Dieckmann2, Stephanie Terezakis3, Louis Constine4.   

Abstract

The optimal management of children with Hodgkin lymphoma (HL) should limit the risk of treatment-related toxicity without compromising disease control. Consequently, increasing effort is being directed to retaining the demonstrated efficacy of radiation therapy (RT) in maximizing the cure of HL while reducing the radiation exposure of normal tissues. Historically, guidelines for RT volume definition used in pediatric HL trials have referenced 2-dimensional imaging and bony landmarks to define classical involved field RT. With recognition of the efficacy of chemotherapy, the data on the adverse late effects of radiation, and the evolution of advanced imaging techniques that reveal the location of both tumor and normal tissues, it is necessary that radiation techniques for children and adolescents be refined. The concepts described by the International Commission on Radiation Units provide a common approach for field definition using 3-dimensional computed tomographic--based RT planning and volumetric image guidance. Here we describe the application of these concepts in the planning of RT for pediatric HL. This will be increasingly important as current and upcoming pediatric HL trials will employ these concepts to deliver RT.
Copyright © 2015 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25413415     DOI: 10.1016/j.prro.2014.05.003

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  13 in total

1.  Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation.

Authors:  Jillian R Gunther; Michelle A Fanale; Jay P Reddy; Mani Akhtari; Grace L Smith; Chelsea C Pinnix; Sarah A Milgrom; Zeinab Abou Yehia; Pamela K Allen; Eleanor M Osborne; Osama Mawlawi; Bouthaina S Dabaja
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-04-13       Impact factor: 7.038

2.  Cardiac MRI for Detecting Early Cardiac Toxicity after Proton Therapy for Hodgkin Lymphoma.

Authors:  James E Bates; Christopher Klassen; Savas Ozdemir; Stella Flampouri; Robert Percy; Nancy P Mendenhall; Bradford S Hoppe
Journal:  Int J Part Ther       Date:  2019-05-07

3.  Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group.

Authors:  Rahul R Parikh; Kara M Kelly; David C Hodgson; Bradford S Hoppe; Kathleen M McCarten; Katie Karolczuk; Qinglin Pei; Yue Wu; Steve Y Cho; Cindy Schwartz; Peter D Cole; Kenneth Roberts
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-11-09       Impact factor: 7.038

4.  Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group.

Authors:  Burton E Appel; Lu Chen; Allen B Buxton; Robert E Hutchison; David C Hodgson; Peter F Ehrlich; Louis S Constine; Cindy L Schwartz
Journal:  J Clin Oncol       Date:  2016-05-16       Impact factor: 44.544

5.  A Comparative Evaluation of Normal Tissue Doses for Patients Receiving Radiation Therapy for Hodgkin Lymphoma on the Childhood Cancer Survivor Study and Recent Children's Oncology Group Trials.

Authors:  Rachel Zhou; Angela Ng; Louis S Constine; Marilyn Stovall; Gregory T Armstrong; Joseph P Neglia; Debra L Friedman; Kara Kelly; Thomas J FitzGerald; David C Hodgson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-04       Impact factor: 7.038

6.  Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines.

Authors:  Bouthaina Shbib Dabaja; Bradford S Hoppe; John P Plastaras; Wayne Newhauser; Katerina Rosolova; Stella Flampouri; Radhe Mohan; N George Mikhaeel; Youlia Kirova; Lena Specht; Joachim Yahalom
Journal:  Blood       Date:  2018-08-14       Impact factor: 22.113

Review 7.  Advances in radiotherapy technology for pediatric cancer patients and roles of medical physicists: COG and SIOP Europe perspectives.

Authors:  Chia-Ho Hua; Anthony E Mascia; Enrica Seravalli; Antony J Lomax; Klaus Seiersen; Kenneth Ulin
Journal:  Pediatr Blood Cancer       Date:  2021-05       Impact factor: 3.167

8.  Vital organ sparing with proton therapy for pediatric Hodgkin lymphoma: Toxicity and outcomes in 50 patients.

Authors:  Kathryn R Tringale; Leslie A Modlin; Kevin Sine; Christopher J Forlenza; Oren Cahlon; Suzanne L Wolden
Journal:  Radiother Oncol       Date:  2022-01-29       Impact factor: 6.901

9.  Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.

Authors:  Sachin R Jhawar; Zorimar Rivera-Núñez; Richard Drachtman; Peter D Cole; Bradford S Hoppe; Rahul R Parikh
Journal:  JAMA Oncol       Date:  2019-05-01       Impact factor: 31.777

10.  Involved site radiation therapy for the treatment of early-stage Hodgkin lymphoma in adolescents and young adults.

Authors:  Carol S Portlock
Journal:  Clin Oncol Adolesc Young Adults       Date:  2015-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.